Related Experiment Video
Updated: Apr 7, 2026
05:55
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
1.5K
The immunogenetics of multiple sclerosis: A comprehensive review
Jill A Hollenbach1, Jorge R Oksenberg1
1Department of Neurology, University of California San Francisco, San Francisco, CA 94158, USA.
Journal of Autoimmunity
|July 5, 2015
Summary
Genetic factors, particularly human leukocyte antigen (HLA) alleles, strongly influence multiple sclerosis (MS) risk. Further research into Killer-cell Immunoglobulin-like Receptor (KIR) and HLA interactions is crucial for understanding MS pathogenesis.
Area of Science:
- Immunogenetics
- Neuroimmunology
- Human Genetics
Background:
- Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease and a leading cause of neurological disability in young adults.
- Genetic susceptibility, influenced by ethnic background and family history, is a key determinant of MS risk.
- While over 100 genetic loci are associated with MS, the human leukocyte antigen (HLA) class II region, particularly HLA-DRB1*15:01, shows the strongest association, explaining significant genetic variance.
Purpose of the Study:
- To explore the complex interplay between Killer-cell Immunoglobulin-like Receptor (KIR) and human leukocyte antigen (HLA) alleles in the context of multiple sclerosis (MS) pathogenesis.
- To highlight the need for advanced multi-locus immunogenomic research to understand the combined impact of genetic variations in MS.
- To address limitations in current studies of KIR in MS, which have relied on low-resolution genotyping.
Main Methods:
- Review of existing literature on genetic associations in MS, focusing on HLA and KIR.
- Discussion of the potential of modern sequencing methodologies and advanced bioinformatics for high-resolution immunogenomic analysis.
- Emphasis on multi-locus immunogenomic approaches to study complex genetic systems.
Main Results:
- The human leukocyte antigen (HLA) region, especially HLA-DRB1*15:01, is a major genetic determinant of MS susceptibility.
- Complex allelic hierarchies, haplotypic effects, and protective signals within the HLA locus are recognized.
- Existing studies on Killer-cell Immunoglobulin-like Receptor (KIR) in MS are limited in scope and resolution.
Conclusions:
- Unifying models are needed to fully elucidate the role of the Major Histocompatibility Complex (MHC) in MS pathogenesis.
- Multi-locus immunogenomic research, integrating HLA and KIR variations, is essential for advancing our understanding of MS.
- Advanced sequencing and analytical techniques are required to appreciate the full impact of HLA and KIR genetic variation in MS.
